Information:
Error:
ID
32693
Description
Study ID: 107038 Clinical Study ID: LPL107038 Study Title: Study to Estimate the Dose Proportionality of the Enteric-Coated Freebase Formulation of SB-480848 Patient Level Data: Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: Tyrisa ,US Study Indication: Atherosclerosis
Keywords
Versions (1)
- 12/11/2018 12/11/2018 -
Copyright Holder
GSK group of companies
Uploaded on
12 novembre 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Estimation of Dose Proportionality of Darapladib - 107038
Pharmacodynamics Post Dose Data - [Analyte and PD sample type]
- StudyEvent: ODM
Similar models
Pharmacodynamics Post Dose Data - [Analyte and PD sample type]
- StudyEvent: ODM
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Dosing date
Item
Dosing date
date
Dosing time
Item
Dosing time
time
Time of sample
Item
Time of sample
time
Time of sample
Item
Time of sample
time
Time of sample
Item
Time of sample
time
Time of sample
Item
Time of sample
time
Time of sample
Item
Time of sample
time
Time of sample
Item
Time of sample
time
Time of sample
Item
Time of sample
time
Time of sample
Item
Time of sample
time
Date of sample
Item
Date of sample
date
Time of sample
Item
Time of sample
time
Date of sample
Item
Date of sample
date
Time of sample
Item
Time of sample
time
Date of sample
Item
Date of sample
date
Time of sample
Item
Time of sample
time
No comments